Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 5
2011 7
2013 2
2016 2
2017 1
2018 1
2019 4
2020 6
2021 5
2022 9
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Mycoplasma pneumoniae: gone forever?
Meyer Sauteur PM, Beeton ML; ESGMAC the ESGMAC MAPS study group. Meyer Sauteur PM, et al. Lancet Microbe. 2023 Oct;4(10):e763. doi: 10.1016/S2666-5247(23)00182-9. Epub 2023 Jun 29. Lancet Microbe. 2023. PMID: 37393927 Free article. No abstract available.
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
Meyer Sauteur PM, Chalker VJ, Berger C, Nir-Paz R, Beeton ML; ESGMAC and the ESGMAC–MyCOVID study group. Meyer Sauteur PM, et al. Lancet Microbe. 2022 Dec;3(12):e897. doi: 10.1016/S2666-5247(22)00190-2. Epub 2022 Aug 11. Lancet Microbe. 2022. PMID: 35964636 Free PMC article. No abstract available.
Mycoplasma pneumoniae detections before and during the COVID-19 pandemic: results of a global survey, 2017 to 2021.
Meyer Sauteur PM, Beeton ML, Uldum SA, Bossuyt N, Vermeulen M, Loens K, Pereyre S, Bébéar C, Keše D, Day J, Afshar B, Chalker VJ, Greub G, Nir-Paz R, Dumke R; ESGMAC–MyCOVID Study Team. Meyer Sauteur PM, et al. Euro Surveill. 2022 May;27(19):2100746. doi: 10.2807/1560-7917.ES.2022.27.19.2100746. Euro Surveill. 2022. PMID: 35551702 Free PMC article.
Multidrug-resistant organisms in patients from Ukraine in the Netherlands, March to August 2022.
Zwittink RD, Wielders CC, Notermans DW, Verkaik NJ, Schoffelen AF, Witteveen S, Ganesh VA, de Haan A, Bos J, Bakker J, Schneeberger-van der Linden C, Kuijper EJ, de Greeff SC, Hendrickx AP; Dutch CPE and MRSA Surveillance Study Groups. Zwittink RD, et al. Among authors: verkaik nj. Euro Surveill. 2022 Dec;27(50):2200896. doi: 10.2807/1560-7917.ES.2022.27.50.2200896. Euro Surveill. 2022. PMID: 36695467 Free PMC article.
Less Is More: When to Repeat Antimicrobial Susceptibility Testing.
Sarink MJ, Bode LGM, Croughs P, de Steenwinkel JEM, Verkaik NJ, van Westreenen M, Vogel M, Yusuf E. Sarink MJ, et al. Among authors: verkaik nj. J Clin Microbiol. 2023 Aug 23;61(8):e0046323. doi: 10.1128/jcm.00463-23. Epub 2023 Jul 12. J Clin Microbiol. 2023. PMID: 37436180 Free PMC article.
Antibiotic treatment of Propionibacterium acnes endocarditis.
Verkaik NJ, Schurink CAM, Melles DC. Verkaik NJ, et al. Clin Microbiol Infect. 2018 Feb;24(2):209. doi: 10.1016/j.cmi.2017.07.024. Epub 2017 Aug 3. Clin Microbiol Infect. 2018. PMID: 28782652 Free article. No abstract available.
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment.
Buis D, van Werkhoven CH, van Agtmael MA, Bax HI, Berrevoets M, de Boer M, Bonten M, Bosmans JE, Branger J, Douiyeb S, Gelinck L, Jong E, Lammers A, Van der Meer J, Oosterheert JJ, Sieswerda E, Soetekouw R, Stalenhoef JE, Van der Vaart TW, Bij de Vaate EA, Verkaik NJ, Van Vonderen M, De Vries PJ, Prins JM, Sigaloff K; Collaborators SAFE-trial study group. Buis D, et al. Among authors: verkaik nj. BMJ Open. 2023 Apr 21;13(4):e068295. doi: 10.1136/bmjopen-2022-068295. BMJ Open. 2023. PMID: 37085305 Free PMC article.
46 results